Japan Peripheral Artery disease: endovaScular revaScularizatION prospective multicenter observational study

Japan Peripheral Artery disease: endovaScular revaScularizatION prospective multicenter observational study - J-PASSION

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010503

Enrollment

550

Registered

2013-07-15

Start date

2013-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20 years old and more. Informed consent obtained. Scheduled endovascular therapy for symptomatic peripheral artery disease.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
Peripheral artery disease overall: Comparison of survival and cardiovascuclar event rates at 3 years between intermittent claudication and critical limb ischemia patients. Comparison of repeat intervention rate at 3 years between intermittent claudication and critical limb ischemia patients. Intermittent claudication group: Improvement rate of Rutherford class at 1 year, Survival and cardiovascular event rates at 3 years. Critical limb ischemia group: Change of visual analogue scale at 1 month, Wound healing rate at 1 year, Limb salvage, survival, amputation-free survival and cardiovascular event rates at 3 years.	—

Measure

Time frame

Peripheral artery disease overall: Comparison of survival and cardiovascuclar event rates at 3 years between intermittent claudication and critical limb ischemia patients. Comparison of repeat intervention rate at 3 years between intermittent claudication and critical limb ischemia patients. Intermittent claudication group: Improvement rate of Rutherford class at 1 year, Survival and cardiovascular event rates at 3 years. Critical limb ischemia group: Change of visual analogue scale at 1 month, Wound healing rate at 1 year, Limb salvage, survival, amputation-free survival and cardiovascular event rates at 3 years.

—

Countries

Japan

Contacts

Public ContactFujishiro

National Cerebral and Cardiovascular Center Medical Research

plandiv@ml.ncvc.go.jp06-6833-5012

Outcome results